Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% compared to the benchmark index [4]. Core Insights - The company reported a revenue of 1.769 billion yuan for H1 2025, representing a year-on-year growth of 30.83%. The net profit attributable to the parent company was 186 million yuan, up 5.21% year-on-year, while the net profit excluding non-recurring items was 177 million yuan, reflecting a 6.64% increase [1]. - The gross margin for H1 2025 was 74.6%, remaining stable year-on-year, while the net margin decreased by 2.58 percentage points to 10.52% due to increased sales expenses [1]. - The company is focusing on a big product strategy, enhancing penetration through key products and new launches, which has contributed to revenue growth [2]. Revenue and Profitability - The company's online channel revenue reached 1.571 billion yuan in H1 2025, accounting for 88.87% of total revenue, with a year-on-year growth of 37.85%. The offline channel revenue was 197 million yuan, down 7.07% [3]. - The report forecasts EPS for 2025, 2026, and 2027 to be 1.14 yuan, 1.45 yuan, and 1.77 yuan respectively, with corresponding P/E ratios of 37, 29, and 24 [4]. Brand and Market Strategy - The main brand, Marubi, is focusing on four key products and three major sets to enhance market penetration, while the PL brand, Lianhuo, is leveraging limited edition products to strengthen user engagement and expand its market [2]. - The company is actively enhancing its online presence through multi-channel operations and has seen significant growth in member transactions and live-stream sales [3].

Investment Rating - The report maintains a "Recommended" rating for the company, with a current price of 45.29 yuan [4]. Core Insights - The company achieved a revenue of 1.769 billion yuan in H1 2025, representing a year-on-year growth of 30.83%. The net profit attributable to shareholders was 186 million yuan, up 5.21% year-on-year [1]. - The skincare segment led revenue growth with 693 million yuan, followed by other beauty categories [1]. - The company continues to deepen its focus on key products, achieving significant technological breakthroughs, including the launch of a new collagen mask that topped sales rankings [3]. - The PL brand also saw growth driven by enhanced product offerings and effective online marketing strategies [3]. Financial Performance - In H1 2025, the gross margin was 74.6%, with a slight decrease of 0.07 percentage points year-on-year. The net profit margin was 10.5%, down 2.56 percentage points year-on-year [2]. - The company plans to distribute a cash dividend of 2.50 yuan per 10 shares, totaling 100 million yuan, which accounts for 53.97% of the net profit for the first half of the year [1]. - Revenue projections for 2025-2027 indicate a steady growth trajectory, with net profits expected to reach 440 million yuan in 2025, 580 million yuan in 2026, and 739 million yuan in 2027 [5][7]. Product and Market Strategy - The main brand, Marubi, focuses on key products and strong brand momentum, while the PL brand is developing a second growth curve in the foundation segment [4]. - The company has launched several new products and marketing campaigns that have significantly increased engagement and sales, particularly through online platforms [3]. Future Outlook - The company is expected to maintain a robust growth rate, with projected net profit growth rates of 27.6% in 2025, 31.8% in 2026, and 27.3% in 2027 [4]. - The current price-to-earnings (PE) ratios for 2025-2027 are projected at 42x, 32x, and 25x respectively, indicating a favorable valuation trend [5][7].